Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CYTOSORBENTS MEDICAL INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-09-24 to 2023-01-23
Current total value of award: $1098588.51
Description: MEDICAL RESEARCH AND DEVELOPMENT CONTRACT DHA SBIR PHASE II PROPOSAL NO. H2S-0005 TITLED DEVELOPMENT OF AN EFFECTIVE ADSORBER TO REMOVE ANTI-A AND ANTI-B ANTIBODIES FROM PLASMA FOR TRANSFUSION. MODIFICATION P00001 COR CHANGE.